The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.

被引：0
|
作者：
Stewart, Grant
Laird, Alexander
O'Mahony, Fiach
Eory, Lel
Lubbock, Alexander
Nanda, Jyoti
O'Donnell, Marie
Mackay, Alan
Mullen, Peter
McNeill, Alan
Riddick, Antony
Aitchison, Michael
Berney, Daniel
Bex, Axel
Overton, Ian
Harrison, David James
Powles, Tom
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Roslin Inst, Edinburgh, Midlothian, Scotland
[3] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland
[4] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England
[5] Univ St Andrews, St Andrews, Fife, Scotland
[6] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England
[7] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
[8] St Bartholomews Hosp, London, England
[9] Netherlands Canc Inst, Amsterdam, Netherlands
[10] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[11] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Relationships between the Effect of Sunitinib and Immature Blood Vessels in Metastatic Renal Cell Cancer
    Kim, Byung Hoon
    Sohn, Jee Chul
    Haa, Ji Young
    Park, Choal Hee
    Choe, Mi Sun
    Jung, Hye Ra
    Kim, Chun Il
    UROLOGIA INTERNATIONALIS, 2015, 94 (02) : 137 - 143
  • [42] Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
    Travnicek, Ivan
    Branzovsky, Jindrich
    Kalusova, Kristyna
    Hes, Ondrej
    Holubec, Lubos
    Pele, Kevin Bauleth
    Urge, Tomas
    Hora, Milan
    ANTICANCER RESEARCH, 2015, 35 (10) : 5661 - 5666
  • [43] VEGF EXPRESSION AS BIOMARKER OF SUNITINIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA
    Bastien, Laurence
    Paule, Bernard
    Maille, Pascale
    Azoulay, Sandy
    Allory, Yves
    Patard, Jean-Jacques
    Rioux-Leclercq, Nathalie
    Crepel, Maxime
    Wallerand, Herve
    Bernhard, Jean-Christophe
    Game, Xavier
    Mazerolles, Catherine
    Guillotreau, Julien
    Ruffion, Alain
    Decaussin-Petrucci, Myriam
    Zini, Laurent
    Leroy, Xavier
    Berton, Nicolas
    Culine, Stephane
    Salomon, Laurent
    Hoznek, Andras
    Vordos, Dimitri
    Abbou, Claude C.
    de la Taille, Alexandre
    JOURNAL OF UROLOGY, 2009, 181 (04): : 108 - 108
  • [44] Heterogeneity of SUVmax in metastatic renal cell cancer and metastatic lung cancer
    Khandani, Amir
    Rybak, Shaun
    Qaqish, Bahjat
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [45] THE EFFICACY OF SUNITINIB IN TARGETED THERAPY OF METASTATIC RENAL CELL CANCER
    Kalpinskiy, A. S.
    Alekseev, B. Y.
    ONKOUROLOGIYA, 2009, 5 (03): : 62 - 66
  • [46] Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer.
    Bjarnason, Georg A.
    Knox, Jennifer J.
    Kollmannsberger, Christian K.
    Soulieres, Denis
    Ernst, D. Scott
    Zalewski, Pawel
    Canil, Christina M.
    Winquist, Eric
    Hotte, Sebastien J.
    North, Scott A.
    Heng, Daniel Yick Chin
    Macfarlane, Robyn Jane
    Venner, Peter M.
    Kapoor, Anil
    Hansen, Aaron Richard
    Eigl, Bernhard J.
    Czaykowski, Piotr
    Boyd, Ben
    Wang, Lisa
    Basappa, Naveen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
  • [48] Sunitinib as first-line therapy in elderly patients (age 70 and older) with metastatic renal cell cancer.
    De Giorgi, Ugo
    Rihawi, Karim
    Lo Re, Giovanni
    Sava, Teodoro
    Masini, Cristina
    Aieta, Michele
    Camerini, Andrea
    Fornarini, Giuseppe
    Burattini, Luciano
    De Vincenzo, Fabio
    Rosti, Giovanni
    Ferrari, Vittorio D.
    Moscetti, Luca
    Chiuri, Vincenzo Emanuele
    Fedeli, Stefano Luzi
    Scarpi, Emanuela
    Basso, Umberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [49] Morphological and molecular heterogeneity in renal cell cancer is exacerbated by treatment with sunitinib
    Stewart, G. D.
    O'Mahony, F. C.
    Eory, L.
    Laird, A.
    Peters, J.
    Riddick, A. C. P.
    McNeill, S. A.
    Aitchison, M.
    Overton, I. M.
    Harrison, D. J.
    Powles, T.
    BJU INTERNATIONAL, 2013, 111 : 64 - 64
  • [50] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Ginsberg, Michelle S.
    Kroog, Glenn
    Tickoo, Satish K.
    Jia, Xiaoyu
    Georges, Murielle
    Patil, Sujata
    Baum, Michael S.
    Reuter, Victor E.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 335 - 340
12345